drugset / Trial / NCT06759584
Management of Temporomandibular Disorders (TMD)
RandomizedParallel-groupDouble-blindTreatment
Summary
Temporomandibular disorders (TMD) are a group of pathologies of the temporomandibular joint, their muscles, and related structures. It is considered a musculoskeletal disorder of the masticatory system, and it has a 25% prevalence in overall population. In 3% - 7% of the population, pain and dysfunction leads to the need for treatment . The etiology of TMD is multifactorial .
Timeline
- Start
- 2023-04-28
- Primary completion
- 2024-02-20
- Completion
- 2024-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexamethasone | Small molecule | — | Topical |